Page 34 - ASPIRE JANUARY 2023 Volume 8 / Issue 1

Empowering
today’s women on
their fertility journeys
Elonva single-injection IVF treatment initiates and sustains multiple follicular growth for 7 days.1-5
The first single-injection sustained follicle stimulant (SFS)5,6
References: 1. Fatemi HM et al, Fertil Steril. 2010;94(5):1922-1924. 2. Fauser BCJM et al, Hum Reprod Update. 2009;15(3):309-321. 3. Griesinger G et al, Eur J Obstet Gynecol Reprod Biol. 2019;232:101-105. 4. Elonva® (corifollitropin alfa) Summary of Product Characteristics (SmPC)22August2014.5. DeGreefRetal,ClinPharmacolTher.2010;88(1):79-87.6.DevroeyPetal,HumReprod.2009;24(12):3063-3072.
Elonva Selected Safety Information Precautions Ovarian Hyperstimulation Syndrome (OHSS); renal insufficiency; ectopic pregnancy; ovarian torsion; congenital malformations; ovarian and other reproductive system neoplasms; thromboembolic events both in association and separate from OHSS; increased risk of multiplets and adverse maternal or perinatal outcomes. Contraindications Hypersensitivity to the active substance or to any of the excipients. Tumours of the ovary, breast, uterus, pituitary or hypothalamus. Abnormal (not menstrual) vaginal bleeding without a known/diagnosed cause. Primary ovarian failure. Ovarian cysts or enlarged ovaries. Fibroid tumors of the uterus incompatible with pregnancy. Malformations of the reproductive organs incompatible with pregnancy. Pregnancy. Risk factors of OHSS e.g a history of OHSS, a previous COS cycle that resulted in more than 30 follicles ≥ 11 mm measured by ultrasound examination, a basal antral follicle count > 20, polycystic ovarian syndrome (PCOS). Adverse Effects Common: OHSS; pelvic pain and discomfort; headache; nausea; fatigue and breast tenderness. Uncommon: Mood swings; dizziness; hot flush; abdominal distension; vomiting; diarrhoea; constipation; back pain; abortion spontaneous; ovarian torsion; adnexa uteri pain; premature ovulation; breast pain; injection site haematoma; injection site pain and irritabili
Full Prescribing Information is available on request.
Please review the Product Information before prescribing at https://bit.ly/3OrlGT5 For healthcare professionals only.
Organon Asia Pacific Services Pte Ltd.
150 Beach Road, Gateway West #36-01/08, Singapore 189720 Tel No.: +65-6983 0780 Fax No.: +65-6983 0779
©2022 Organon group of companies. All rights reserved.
ORGANON and the ORGANON Logo are trademarks of the Organon group of companies. SC-ELO-110006 NOV/2022